These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30947879)

  • 1. Liver Disease in Human Immunodeficiency Virus Infection.
    Oikonomou KG; Tsai E; Sarpel D; Dieterich DT
    Clin Liver Dis; 2019 May; 23(2):309-329. PubMed ID: 30947879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing burden of liver disease in patients with HIV infection.
    Joshi D; O'Grady J; Dieterich D; Gazzard B; Agarwal K
    Lancet; 2011 Apr; 377(9772):1198-209. PubMed ID: 21459211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities.
    Abarca JC; Huerta L; Fierro NA
    Ann Hepatol; 2020; 19(2):121-122. PubMed ID: 32138869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Liver Pathology.
    Sonderup MW; Wainwright HC
    Gastroenterol Clin North Am; 2017 Jun; 46(2):327-343. PubMed ID: 28506368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver involvement in human immunodeficiency virus infection.
    Puri P; Kumar S
    Indian J Gastroenterol; 2016 Jul; 35(4):260-73. PubMed ID: 27256434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hepatic complications in HIV-infected persons.
    Sulkowski MS
    J Infect Dis; 2008 May; 197 Suppl 3():S279-93. PubMed ID: 18447614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection.
    Bonacini M
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S104-8. PubMed ID: 14986282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-related liver disease: ARV drugs, coinfection, and other risk factors.
    Puoti M; Nasta P; Gatti F; Matti A; Prestini K; Biasi L; Carosi G
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):30-42. PubMed ID: 19211929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
    Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
    Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antiretroviral therapy on liver disease.
    Kovari H; Weber R
    Curr Opin HIV AIDS; 2011 Jul; 6(4):272-7. PubMed ID: 21508839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the management of HIV/HCV coinfection.
    Mandorfer M; Schwabl P; Steiner S; Reiberger T; Peck-Radosavljevic M
    Hepatol Int; 2016 May; 10(3):424-35. PubMed ID: 26758592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-"Liver"-ing HIV/hepatitis C virus-coinfected patients from antiretroviral hepatotoxicity.
    Cooper CL
    J Infect Dis; 2007 Sep; 196(5):656-8. PubMed ID: 17674305
    [No Abstract]   [Full Text] [Related]  

  • 15. Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection.
    Nampala H; Luboobi LS; Mugisha JYT; Obua C; Jablonska-Sabuka M
    Math Biosci; 2018 Aug; 302():67-79. PubMed ID: 29800563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
    Pol S; Lebray P; Vallet-Pichard A
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S65-72. PubMed ID: 14986277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus and liver disease: An update.
    Sherman KE; Rockstroh J; Thomas D
    Hepatology; 2015 Dec; 62(6):1871-82. PubMed ID: 26340591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver disease in the HIV-infected individual.
    Price JC; Thio CL
    Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1002-12. PubMed ID: 20851211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
    Crespo M; Navarro J; Moreno S; Sanz J; Márquez M; Zamora J; Ocampo A; Iribaren JA; Rivero A; Llibre JM
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):493-498. PubMed ID: 27061975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.